In a real-world clinical trial, published in JAMA Network Open, researchers demonstrate that a fully digital AI zero-cost method for detecting dementia can be scaled across primary care clinics. This breakthrough represents a major step forward in translating AI and patient-reported outcomes into everyday clinical care. By integrating scalable digital tools that operate seamlessly within existing health systems, the research team demonstrated how technology can strengthen early detection and improve outcomes for older adults as well as reduce burdens on primary care teams.  The AI tool, which has been in development for more than 10 years at Regenstrief Institute, is a machine learning algorithm that uses natural language processing to analyze data from electronic health records. It identifies information such as memory issues, vascular concerns and other factors linked to dementia.